James M. Gray

1.4k total citations
51 papers, 895 citations indexed

About

James M. Gray is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, James M. Gray has authored 51 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Cardiology and Cardiovascular Medicine and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in James M. Gray's work include Blood Pressure and Hypertension Studies (7 papers), Epilepsy research and treatment (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). James M. Gray is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Epilepsy research and treatment (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). James M. Gray collaborates with scholars based in United States, United Kingdom and Italy. James M. Gray's co-authors include Gilberto Levy, Jessica O’Hagen, Connie Garland, P. Kaufmann, Maryam Oskoui, Darryl C. De Vivo, David H. Lawson, Matthew R. Weir, Elijah Saunders and Robert Zorba Paster and has published in prestigious journals such as Gastroenterology, Neurology and PEDIATRICS.

In The Last Decade

James M. Gray

46 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James M. Gray United States 14 209 201 184 171 157 51 895
Clark Paramore United States 11 87 0.4× 339 1.7× 87 0.5× 93 0.5× 134 0.9× 26 1.1k
Claus Bistrup Denmark 21 53 0.3× 84 0.4× 268 1.5× 415 2.4× 322 2.1× 88 1.3k
Y. Francès France 15 31 0.1× 311 1.5× 167 0.9× 82 0.5× 196 1.2× 76 914
Emanuela D’Angelo Italy 17 83 0.4× 130 0.6× 106 0.6× 151 0.9× 95 0.6× 36 1.3k
Ralf Westerhuis Netherlands 21 29 0.1× 277 1.4× 370 2.0× 138 0.8× 156 1.0× 61 1.5k
A. Prins Netherlands 21 37 0.2× 54 0.3× 194 1.1× 211 1.2× 124 0.8× 25 1.2k
Marcin Tkaczyk Poland 16 39 0.2× 99 0.5× 98 0.5× 160 0.9× 115 0.7× 99 1.1k
Duke Appiah United States 18 48 0.2× 319 1.6× 105 0.6× 100 0.6× 129 0.8× 81 1.2k
A. Böck Switzerland 14 139 0.7× 36 0.2× 169 0.9× 49 0.3× 146 0.9× 32 1.0k
Vidhu Anand United States 18 72 0.3× 312 1.6× 138 0.8× 78 0.5× 235 1.5× 53 924

Countries citing papers authored by James M. Gray

Since Specialization
Citations

This map shows the geographic impact of James M. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Gray more than expected).

Fields of papers citing papers by James M. Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Gray. The network helps show where James M. Gray may publish in the future.

Co-authorship network of co-authors of James M. Gray

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Gray. A scholar is included among the top collaborators of James M. Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Gray. James M. Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rudinsky, Sherri L, et al.. (2023). What to know about 2.0: Revisions to the pediatric emergency medicine milestones. AEM Education and Training. 7(2). e10865–e10865. 2 indexed citations
3.
Samsky, Marc D., et al.. (2023). Patient Perspectives on Digital Interventions to Manage Heart Failure Medications: The VITAL-HF Pilot. Journal of Clinical Medicine. 12(14). 4676–4676. 7 indexed citations
4.
Gray, James M., et al.. (2022). Hepatic Lesions in an Immunocompetent Child Previously Treated for Cat Scratch Disease With Azithromycin. Clinical Pediatrics. 62(3). 191–194.
5.
Rao, Vishal N., James M. Gray, Jeroen Molinger, et al.. (2022). Quantitative Blood Volume Analysis and Hemodynamic Measures of Vascular Compliance in Patients With Worsening Heart Failure. Journal of Cardiac Failure. 28(9). 1469–1474. 7 indexed citations
6.
Walsh, Patrick S., James M. Gray, Sriram Ramgopal, & Matthew J. Lipshaw. (2021). Risk of malignancy following emergency department Bell's palsy diagnosis in children. The American Journal of Emergency Medicine. 53. 63–67. 1 indexed citations
7.
Gray, James M., et al.. (2020). Fecal Lactoferrin and Other Stool Markers during Normal Pregnancy and in Inflammatory Bowel Diseases: A Prospective Study and Review of the Literature. Inflammatory Intestinal Diseases. 5(3). 151–158. 1 indexed citations
8.
Gray, James M., et al.. (2019). Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease. World Journal of Gastrointestinal Pathophysiology. 10(5). 54–63. 14 indexed citations
9.
Gray, James M., et al.. (2018). Procedural sedation in children with autism spectrum disorders in the emergency department. The American Journal of Emergency Medicine. 37(8). 1404–1408. 14 indexed citations
10.
Gray, James M., et al.. (2017). Ondansetron Prescription for Home Use in a Pediatric Emergency Department. Pediatric Emergency Care. 36(3). e120–e124. 8 indexed citations
11.
Cohen, Philip R., et al.. (2011). Prolactinoma presenting as unilateral galactorrhea in a man exposed to radioactivity from the Chernobyl accident: radiation‐induced pituitary tumor?. International Journal of Dermatology. 50(6). 722–725. 1 indexed citations
12.
Riahi, Ryan R, et al.. (2010). Erythema ab igne mimicking livedo reticularis. International Journal of Dermatology. 49(11). 1314–1317. 14 indexed citations
13.
Cohen, Philip R, et al.. (2009). Recurrent Episodes of Painful and Pruritic Red Skin Lesions. American Journal of Clinical Dermatology. 11(1). 73–78. 9 indexed citations
14.
Gradman, Alan H., et al.. (1999). Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Clinical Therapeutics. 21(3). 442–453. 31 indexed citations
15.
Gray, James M., et al.. (1988). Comparison of labetalol and prazosin in hypertensive patients using automated ambulatory monitoring. The American Journal of Medicine. 84(5). 904–910. 3 indexed citations
16.
Kesson, C. M., et al.. (1984). Long‐Term Efficacy and Tolerability of a New Hypnotic‐Loprazolam. International Journal of Clinical Practice. 38(9). 306–312. 4 indexed citations
17.
Gray, James M., et al.. (1983). Hyperkalaemia in patients in hospital.. BMJ. 286(6372). 1189–1192. 88 indexed citations
18.
Lawson, David H., et al.. (1982). Effect of Furosemide on the Pharmacokinetics of Gentamicin in Patients. The Journal of Clinical Pharmacology. 22(5-6). 254–258. 13 indexed citations
19.
Gray, James M., et al.. (1979). Adverse reactions to frusemide in hospital inpatients.. BMJ. 2(6186). 360–362. 34 indexed citations
20.
Jenkins, Daniel E., et al.. (1977). Chemical Pneumonitis Secondary to Inhalation of Epoxy Pipe Coating. Archives of Environmental Health An International Journal. 32(4). 173–178. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026